1

CGRP Inhibitors in Ocular Migraine Management: Market Sizing, Adoption Rate, and Revenue Forecast by Drug Type (Oral/Injectable), 2025–2032.

News Discuss 
The global Ocular Migraine Market is on a trajectory of substantial growth, driven by increasing awareness, advancements in diagnostic technologies, and the rising prevalence of migraine-related visual disturbances worldwide. A new market analysis indicates the market size, valued at USD 90.04 million in 2024, is expected to nearly double, reaching USD 171.53 million by 2032. This exp... https://in.linkedin.com/company/data-bridge-market-research

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story